NSW Cancer Research Education State-wide Seminar Series May 2026
Location: online webinar
Sydney Cancer Partners, in collaboration with Maridulu Budyari Gumal (SPHERE) Cancer CAG and the NSW Regional Cancer Research Network, will be hosting the 2026 NSW Cancer Research Education State-wide Seminar Series.
These online seminars will be held on the 3rd Tuesday of each month.
Molecular Tumour Board – Precision treatment for cancer of the thyroid
A Molecular Tumour Board (MTB) is a multi-disciplinary forum for discussion, interpretation and communication about molecular results that may have implications for patient care. The NSW Cancer Research Education Seminar Series features educational Molecular Tumour Board (MTB) sessions, including case-based presentations from MTBs working across both paediatric and adult cancers.
This session will cover anatomy and histology of thyroid, and pathology and molecular advances in thyroid cancer with a focus on improving diagnostic accuracy and opening treatment pathway.
The presentations will be followed by a Q&A.
Speakers
Professor Ruta Gupta. Clinical Director, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology; Sydney Medical School, The University of Sydney
Associate Professor Michael Elliott. Head & Neck Surgeon, Royal Prince Alfred Hospital & Chris O’Brien Lifehouse; Sydney Medical School, The University of Sydney
Dr Peter Luk. Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology
Chair: Clinical Professor Rosemary Balleine. Clinical and Strategic Partnerships Lead, Sydney Cancer Partners.